NSTG
NanoString Technologies, Inc.
Set alert
52-week range unavailable
- Open
- 0.128
- Prev close
- 0.1053
- Mkt cap
- 5.07M
- Vol
- 21.43M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1025
- High
- 0.13999
- Forward P/E
- -0.06
- Beta
- 1.24
- Short ratio
- 6.63
- Inst. own
- 106.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 27, 2024
- 50-d avg
- 0.403199
- 200-d avg
- 2.15
- 1y target
- 0.25
Key statistics
- Market cap
- 5.07M
- Enterprise value
- 154.02M
- Trailing P/E
- 0.00
- Forward P/E
- -0.06
- PEG ratio
- 0.00
- Price / sales
- 0.03
- Price / book
- 0.00
- EPS (TTM)
- -3.53
- Beta
- 1.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -102.44%
- Revenue (TTM)
- 162.47M
- Revenue growth
- 62.80%
- Free cash flow
- -81.48M
- Total cash
- 97.10M
- Total debt
- 247.70M
- Return on equity
- -1028.56%
- Shares outstanding
- 48.12M
- Short % of float
- 16.67%
- 50-day average
- 0.403199
- 200-day average
- 2.15
Analyst view
Consensus: buy
- Strong buy1
- Buy1
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 27, 2024
Expected Feb 27, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 27, 2024 | Dec 1, 2023 | -0.47 | — | — | — |
| Nov 6, 2023 | Sep 1, 2023 | -0.53 | — | — | — |
| Aug 3, 2023 | Jun 1, 2023 | -0.70 | — | — | — |
| May 3, 2023 | Mar 1, 2023 | -0.72 | — | — | — |
| Feb 28, 2023 | Dec 1, 2022 | -0.61 | — | — | — |
| Nov 7, 2022 | Sep 1, 2022 | -0.46 | — | — | — |
About NanoString Technologies, Inc.
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- nanostring.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on NSTG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEECHEM JOSEPH M | Officer | Stock Award(Grant) | Aug 31, 2023 | 95,017 |
| FINNEY ELISHA W | Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 21,446 |
| FOY TERESA M. | Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 6,275 |
| GEORGE JANET | Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 19,268 |
| GRAY ROBERT BRADLEY | Chief Executive Officer | Stock Award(Grant) | Aug 31, 2023 | 338,682 |
| MALLOY KIRK | Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 24,251 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Polar Capital Holdings PLC | 8.26% | 3,975,000 | 418.57K | Dec 30, 2023 |
| Blackrock Inc. | 7.43% | 3,574,938 | 376.44K | Dec 30, 2023 |
| Vanguard Group Inc | 7.42% | 3,569,859 | 375.91K | Sep 29, 2023 |
| Platinum Investment Management Ltd | 5.77% | 2,775,853 | 292.30K | Dec 30, 2023 |
| Morgan Stanley | 4.85% | 2,333,231 | 245.69K | Dec 30, 2023 |
| Avidity Partners Management, LP | 4.78% | 2,299,100 | 242.09K | Sep 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.93% | 1,409,732 | 148.44K | Sep 29, 2023 |
| iShares Russell 2000 ETF | 2.74% | 1,319,049 | 138.90K | Dec 30, 2023 |
| Vanguard Extended Market Index Fund | 1.41% | 679,551 | 71.56K | Sep 29, 2023 |
| Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 1.09% | 522,901 | 55.06K | Sep 29, 2023 |
| Fidelity Small Cap Index Fund | 0.95% | 457,678 | 48.19K | Nov 29, 2023 |
| iShares Russell 2000 Growth ETF | 0.80% | 384,596 | 40.50K | Dec 30, 2023 |